Peanut allergies continue to be a major concern in public health, especially among children and adolescents. Characterized by severe, potentially life-threatening reactions, this condition affects millions worldwide. As awareness grows and diagnostic tools improve, the focus is shifting from avoidance to active immunotherapeutic interventions. According to DelveInsight’s “Peanut Allergy Market: Emerging Therapeutics and Market Landscape Read.